These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 28061468)
1. The heterogeneous landscape of ALK negative ALCL. Mereu E; Pellegrino E; Scarfò I; Inghirami G; Piva R Oncotarget; 2017 Mar; 8(11):18525-18536. PubMed ID: 28061468 [TBL] [Abstract][Full Text] [Related]
2. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous. Xing X; Feldman AL Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779 [TBL] [Abstract][Full Text] [Related]
3. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Agnelli L; Mereu E; Pellegrino E; Limongi T; Kwee I; Bergaggio E; Ponzoni M; Zamò A; Iqbal J; Piccaluga PP; Neri A; Chan WC; Pileri S; Bertoni F; Inghirami G; Piva R; Blood; 2012 Aug; 120(6):1274-81. PubMed ID: 22740451 [TBL] [Abstract][Full Text] [Related]
4. Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma. Wang X; Wu J; Zhang M Hematology; 2019 Dec; 24(1):440-445. PubMed ID: 31072226 [TBL] [Abstract][Full Text] [Related]
5. ALCL by any other name: the many facets of anaplastic large cell lymphoma. Irshaid L; Xu ML Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671 [TBL] [Abstract][Full Text] [Related]
6. Genetics of anaplastic large cell lymphoma. Zeng Y; Feldman AL Leuk Lymphoma; 2016; 57(1):21-7. PubMed ID: 26104084 [TBL] [Abstract][Full Text] [Related]
7. Pathology and genetics of anaplastic large cell lymphoma. Leventaki V; Bhattacharyya S; Lim MS Semin Diagn Pathol; 2020 Jan; 37(1):57-71. PubMed ID: 31882178 [TBL] [Abstract][Full Text] [Related]
8. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Parrilla Castellar ER; Jaffe ES; Said JW; Swerdlow SH; Ketterling RP; Knudson RA; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Vasmatzis G; Gibson SE; Ondrejka S; Nicolae A; Grogg KL; Allmer C; Ristow KM; Wilson WH; Macon WR; Law ME; Cerhan JR; Habermann TM; Ansell SM; Dogan A; Maurer MJ; Feldman AL Blood; 2014 Aug; 124(9):1473-80. PubMed ID: 24894770 [TBL] [Abstract][Full Text] [Related]
9. Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management. Shustov A; Soma L Cancer Treat Res; 2019; 176():127-144. PubMed ID: 30596216 [TBL] [Abstract][Full Text] [Related]
10. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048 [TBL] [Abstract][Full Text] [Related]
11. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination. ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802 [TBL] [Abstract][Full Text] [Related]
12. Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas. Boi M; Zucca E; Inghirami G; Bertoni F Br J Haematol; 2015 Mar; 168(6):771-83. PubMed ID: 25559471 [TBL] [Abstract][Full Text] [Related]
13. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified. ten Berge RL; de Bruin PC; Oudejans JJ; Ossenkoppele GJ; van der Valk P; Meijer CJ Histopathology; 2003 Nov; 43(5):462-9. PubMed ID: 14636272 [TBL] [Abstract][Full Text] [Related]
14. Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases. Agrawal K; Shet T; Sridhar E; Dhende S; Sengar M; Arora B; Laskar S; Gujral S; Menon H; Banavali S Indian J Pathol Microbiol; 2017; 60(4):533-540. PubMed ID: 29323068 [TBL] [Abstract][Full Text] [Related]
15. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546 [TBL] [Abstract][Full Text] [Related]
16. Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma. Mehrotra M; Medeiros LJ; Luthra R; Sargent RL; Yao H; Barkoh BA; Singh R; Patel KP Hum Pathol; 2014 Oct; 45(10):1995-2005. PubMed ID: 25128227 [TBL] [Abstract][Full Text] [Related]
17. The biology and management of systemic anaplastic large cell lymphoma. Hapgood G; Savage KJ Blood; 2015 Jul; 126(1):17-25. PubMed ID: 25869285 [TBL] [Abstract][Full Text] [Related]
18. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules. Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575 [TBL] [Abstract][Full Text] [Related]
19. ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient. Pulitzer M; Ogunrinade O; Lin O; Steinherz P J Cutan Pathol; 2015 Mar; 42(3):182-187. PubMed ID: 25404214 [TBL] [Abstract][Full Text] [Related]
20. Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? Fornari A; Piva R; Chiarle R; Novero D; Inghirami G Hematol Oncol; 2009 Dec; 27(4):161-70. PubMed ID: 19358142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]